These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 9728127)

  • 1. Minimally invasive therapies for the treatment of symptomatic benign prostatic hyperplasia: the University of Florida experience.
    Narayan P; Starling J
    J Clin Laser Med Surg; 1998 Feb; 16(1):29-32. PubMed ID: 9728127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimally invasive surgery in the management of benign prostatic hyperplasia.
    Berardinelli F; Hinh P; Wang R
    Minerva Urol Nefrol; 2009 Sep; 61(3):269-89. PubMed ID: 19773728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of minimally invasive surgeries for the treatment of symptomatic benign prostatic hyperplasia on male sexual function: a systematic review.
    Frieben RW; Lin HC; Hinh PP; Berardinelli F; Canfield SE; Wang R
    Asian J Androl; 2010 Jul; 12(4):500-8. PubMed ID: 20473318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent developments in the surgical management of benign prostatic hyperplasia.
    Jepsen JV; Bruskewitz RC
    Urology; 1998 Apr; 51(4A Suppl):23-31. PubMed ID: 9586593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update in minimal invasive therapy in benign prostatic hyperplasia.
    Van Hest P; D'Ancona F
    Minerva Urol Nefrol; 2009 Sep; 61(3):257-68. PubMed ID: 19773727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome analysis of minimally invasive treatments for benign prostatic hyperplasia.
    Djavan B; Madersbacher S; Klingler HC; Ghawidel K; Basharkhah A; Hruby S; Seitz C; Marberger M
    Tech Urol; 1999 Mar; 5(1):12-20. PubMed ID: 10374789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newly developed equipment and methods in the treatment of BPH: analysis of present status.
    Tazaki H; Baba S; Nakamura K; Tachibana M; Nakashima J; Nakagawa K; Deguchi N
    Int J Urol; 1996 Jan; 3(1 Suppl):S48-52. PubMed ID: 24304024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Old and new interventional therapies in the treatment of symptomatic benign prostate hyperplasia (BPH)].
    Müller RM; Thalmann GN; Studer UE
    Ther Umsch; 2006 Feb; 63(2):129-34. PubMed ID: 16514965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transurethral resection versus minimally invasive treatments of benign prostatic hyperplasia: results of treatments. Our experience.
    Minardi D; Galosi AB; Yehia M; Cristalli A; Hanitzsch H; Polito M; Muzzonigro G
    Arch Ital Urol Androl; 2004 Mar; 76(1):11-8. PubMed ID: 15185816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Surgical and instrumental management of benign prostatic hyperplasia].
    Muschter R; Reich O
    Urologe A; 2008 Feb; 47(2):155-65. PubMed ID: 18265958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The early postoperative morbidity of transurethral resection of the prostate and of 4 minimally invasive treatment alternatives.
    Schatzl G; Madersbacher S; Lang T; Marberger M
    J Urol; 1997 Jul; 158(1):105-10; discussion 110-1. PubMed ID: 9186334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The University of Tennessee experience with the Indigo 830e laser device for the minimally invasive treatment of benign prostatic hyperplasia: interim analysis.
    Greenberger M; Steiner MS
    World J Urol; 1998; 16(6):386-91. PubMed ID: 9870285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Durability and retreatment rates of minimal invasive treatments of benign prostatic hyperplasia: a cross-analysis of the literature.
    Djavan B; Eckersberger E; Handl MJ; Brandner R; Sadri H; Lepor H
    Can J Urol; 2010 Aug; 17(4):5249-54. PubMed ID: 20735902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends and attitudes in surgical management of benign prostatic hyperplasia.
    Lee NG; Xue H; Lerner LB
    Can J Urol; 2012 Apr; 19(2):6170-5. PubMed ID: 22512959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the holmium:YAG laser for prostatectomy.
    Kabalin JN; Gilling PJ; Fraundorfer MR
    J Clin Laser Med Surg; 1998 Feb; 16(1):21-7. PubMed ID: 9728126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laser therapy for benign prostatic hyperplasia: a review of recent developments.
    Aho TF; Gilling PJ
    Curr Opin Urol; 2003 Jan; 13(1):39-44. PubMed ID: 12490814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical study of transurethral electrovaporization of the prostate for benign prostatic hyperplasia].
    Yajima M; Takemura H; Nishida S; Matsushita T; Yanagisawa N; Baba K; Iwamoto T
    Hinyokika Kiyo; 1999 Sep; 45(9):609-12. PubMed ID: 10540705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevalence and preference with regard to various surgical treatments for benign prostatic hypertrophy: a survey for the Japanese endourology and ESWL society member].
    Seki N; Naito S; Oshima S; Hirao Y; Higashihara E
    Nihon Hinyokika Gakkai Zasshi; 2003 May; 94(4):495-502. PubMed ID: 12795164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transurethral needle ablation Prostiva for treating symptomatic benign prostatic hyperplasia: a review].
    Xylinas E; Le Gal S; Descazeaud A
    Prog Urol; 2010 Sep; 20(8):566-71. PubMed ID: 20832033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High temperature radiofrequency transurethral ablation of the prostate (TURAPY).
    Popov AI; Vasilevsky SI
    Wiad Lek; 1997; 50 Suppl 1 Pt 2():272-4. PubMed ID: 9383360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.